List of Studies ( Metabolite:SHexCer 18:1;O2/20:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST001819 | AN002951 | EC and PVC from 14-15 month-old APOE3/3, APOE3/4 and APOE4/4 mice | Brain | Mouse | Alzheimers disease | Columbia University | area under the curve |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST000445 | AN000696 | Follicular fluid lipidomics reveals lipid alterations by LH addition during IVF cycles | Follicular fluid | Human | Universidade Federal de Sao Paulo | Peak intensity | |
| ST002452 | AN004007 | Lipidomic analysis of human brain from frontotemporal dementia cases of with GRN and C9orf72 mutations | Brain | Human | Dementia | The University of Sydney | pmoles/mg protein |
| ST002928 | AN004802 | The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus | Brain | Human | Dementia | University of Sydney | % Total |
